loaderimg
image

STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America.

Company’s Keywords:

healthcare, medical devices, logistics, medical, health care, stent, coronary artery disease, ami, acs, bifurcation, nitinol, selfapposing stent, selfexpanding stent, des, bms, aspiration catheter

Q How Many Employees Does This Company Have?

<18

Q Which Industry Does This Company Belong To?

Q What Is the Annual Income?

<6405000

Q What Is the Technology of All the Company’s Website?

Q What Year Was the Company Founded?

<2006

Rate us and Write a Review

Your review is recommended to be at least 140 characters long

image

building Own or work here? Claim Now! Claim Now!

imageYour request has been submitted successfully.

image